[Clinical utility of the bispectral index for detecting epileptic seizures].
Guerrero
J J
JJ
Alsina
E
E
Del Blanco
B
B
Matute
E
E
D018685:Anesthetics, Inhalation / Q000494:pharmacology; D018686:Anesthetics, Intravenous / Q000494:pharmacology; D000927:Anticonvulsants / Q000627:therapeutic use; D002540:Cerebral Cortex / Q000503:physiopathology; D003131:Combined Modality Therapy; D046690:Deep Brain Stimulation / Q000295:instrumentation; D004351:Drug Resistance; D004567:Electrodes, Implanted; D004569:Electroencephalography / Q000187:drug effects / Q000379:methods*; D019277:Entropy; D004829:Epilepsy, Generalized / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology / Q000601:surgery; D006801:Humans; D007431:Intraoperative Complications / Q000175:diagnosis* / Q000503:physiopathology; D008738:Methyl Ethers / Q000494:pharmacology; D016343:Monitoring, Intraoperative / Q000379:methods*; D019635:Neurosurgical Procedures; D010880:Piperidines / Q000494:pharmacology; D011183:Postoperative Complications / Q000175:diagnosis* / Q000188:drug therapy / Q000503:physiopathology; D015742:Propofol / Q000627:therapeutic use; D000077208:Remifentanil; D000077149:Sevoflurane; D014630:Vagus Nerve
D018685:Anesthetics, Inhalation; D018686:Anesthetics, Intravenous; D000927:Anticonvulsants; D008738:Methyl Ethers; D010880:Piperidines; D000077149:Sevoflurane; D000077208:Remifentanil; D015742:Propofol